Clene Inc

NASDAQ:CLNN  
11.09
-0.76 (-6.41%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)36.04M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.08 Million
Adjusted EPS-$0.16
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Clene Inc Stock, NASDAQ:CLNN

6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121
Virgin Islands, British
Phone: +1.801.676.9695
Number of Employees:

Description

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.